Imperial College London

ProfessorDavidCarling

Faculty of MedicineInstitute of Clinical Sciences

Professor of Biochemistry
 
 
 
//

Contact

 

+44 (0)20 3313 4313david.carling

 
 
//

Location

 

3rd Fl CRBHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Boyle:2017,
author = {Boyle, JJ and Seneviratne, AA and Haskard, DO and Carling, D and Hyde, G},
pages = {8--9},
publisher = {KARGER},
title = {Oral Metformin Profoundly Suppresses Atherosclerotic Lesion Development In Vivo Independently of Glucose Lowering in a Mild Hyperlipidemic Model Via AMPK},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402740200020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Boyle,JJ
AU - Seneviratne,AA
AU - Haskard,DO
AU - Carling,D
AU - Hyde,G
EP - 9
PB - KARGER
PY - 2017///
SN - 1018-1172
SP - 8
TI - Oral Metformin Profoundly Suppresses Atherosclerotic Lesion Development In Vivo Independently of Glucose Lowering in a Mild Hyperlipidemic Model Via AMPK
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402740200020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -